Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose–Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer
Objectives
We investigated the [18F]-fluoro-2-deoxy-d-glucose (FDG)–positron emission tomography (PET)/computed tomography (CT) findings of pancreatic and extrapancreatic lesions in patients with autoimmune pancreatitis (AIP) and pancreatic cancer (PC) and evaluated the usefulness of 18F-FDG–PET/CT for differentiating between AIP and PC.
Methods
Eighty-five patients, 19 with AIP and 66 with PC, who underwent 18F-FDG–PET/CT were studied retrospectively. We evaluated the maximum standardized uptake value (SUVmax), patterns and distributions of FDG activity in pancreatic lesions, as well as FDG uptake in extrapancreatic lesions.
Results
The levels of SUVmax of pancreatic lesions in PC patients were significantly higher than those in AIP patients (P
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Gastroenterology | Pancreas | Pancreatic Cancer | Pancreatitis | PET Scan